The effects of child abuse and neglect on cognitive functioning in adulthood.

PubWeight™: 1.01‹?› | Rank: Top 15%

🔗 View Article (PMC 3307950)

Published in J Psychiatr Res on February 14, 2012

Authors

Felicia Gould1, Jennifer Clarke, Christine Heim, Philip D Harvey, Matthias Majer, Charles B Nemeroff

Author Affiliations

1: Department of Psychiatry and Behavioral Sciences, University of Miami Leonard M. Miller School of Medicine, Miami, FL 33136, USA.

Articles citing this

Social influences on neuroplasticity: stress and interventions to promote well-being. Nat Neurosci (2012) 2.49

Annual Research Review: Enduring neurobiological effects of childhood abuse and neglect. J Child Psychol Psychiatry (2016) 1.76

Pathways Associating Childhood Trauma to the Neurobiology of Schizophrenia. Front Psychol Behav Sci (2014) 0.88

Pathological brain plasticity and cognition in the offspring of males subjected to postnatal traumatic stress. Mol Psychiatry (2014) 0.85

COGNITION-CHILDHOOD MALTREATMENT INTERACTIONS IN THE PREDICTION OF ANTIDEPRESSANT OUTCOMES IN MAJOR DEPRESSIVE DISORDER PATIENTS: RESULTS FROM THE iSPOT-D TRIAL. Depress Anxiety (2015) 0.81

Child maltreatment and executive functioning in middle adulthood: a prospective examination. Neuropsychology (2013) 0.81

Negative childhood experiences alter a prefrontal-insular-motor cortical network in healthy adults: A preliminary multimodal rsfMRI-fMRI-MRS-dMRI study. Hum Brain Mapp (2015) 0.80

Exposure to childhood trauma is associated with altered n-back activation and performance in healthy adults: implications for a commonly used working memory task. Brain Imaging Behav (2016) 0.79

Epigenetic pathways through which experiences become linked with biology. Dev Psychopathol (2015) 0.78

Epigenetics of Stress, Addiction, and Resilience: Therapeutic Implications. Mol Neurobiol (2014) 0.78

On the incidence and prevalence of child maltreatment: a research agenda. Child Adolesc Psychiatry Ment Health (2016) 0.77

Does developmental timing of exposure to child maltreatment predict memory performance in adulthood? Results from a large, population-based sample. Child Abuse Negl (2015) 0.77

Long-term effect of early-life stress from earthquake exposure on working memory in adulthood. Neuropsychiatr Dis Treat (2015) 0.77

Polygenic Risk of Schizophrenia and Cognition in a Population-Based Survey of Older Adults. Schizophr Bull (2016) 0.77

Reversal learning deficits in criminal offenders: Effects of psychopathy, substance use, and childhood maltreatment history. J Psychopathol Behav Assess (2016) 0.75

Neurofunctional Abnormalities during Sustained Attention in Severe Childhood Abuse. PLoS One (2016) 0.75

Investigating the separate and interactive associations of trauma and depression on neurocognition in urban dwelling adults. J Psychiatr Res (2017) 0.75

Child maltreatment and quality of life: a study of adolescents in residential care. Health Qual Life Outcomes (2016) 0.75

Interpersonal early-life trauma alters amygdala connectivity and sustained attention performance. Brain Behav (2017) 0.75

Childhood abuse and neglect may induce deficits in cognitive precursors of psychosis in high-risk children. J Psychiatry Neurosci (2015) 0.75

Late-Onset Cognitive Impairments after Early-Life Stress Are Shaped by Inherited Differences in Stress Reactivity. Front Cell Neurosci (2017) 0.75

Cortisol Profile Mediates the Relation Between Childhood Neglect and Pain and Emotional Symptoms among Patients with Fibromyalgia. Ann Behav Med (2016) 0.75

Evidence That the Impact of Childhood Trauma on IQ Is Substantial in Controls, Moderate in Siblings, and Absent in Patients With Psychotic Disorder. Schizophr Bull (2017) 0.75

Adverse childhood experience effects on opioid use initiation, injection drug use, and overdose among persons with opioid use disorder. Drug Alcohol Depend (2017) 0.75

Impact of juvenile chronic stress on adult cortico-accumbal function: Implications for cognition and addiction. Prog Neuropsychopharmacol Biol Psychiatry (2017) 0.75

Articles cited by this

Stress and the brain: from adaptation to disease. Nat Rev Neurosci (2005) 9.48

A structured interview guide for the Hamilton Depression Rating Scale. Arch Gen Psychiatry (1988) 8.53

The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies. Biol Psychiatry (2001) 7.80

Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood. JAMA (2000) 7.21

Depression: perspectives from affective neuroscience. Annu Rev Psychol (2002) 3.72

The interrelationship of neuroticism, sex, and stressful life events in the prediction of episodes of major depression. Am J Psychiatry (2004) 3.09

Computerized assessment in neuropsychiatry using CANTAB: discussion paper. J R Soc Med (1992) 3.00

Interactions between BDNF Val66Met polymorphism and early life stress predict brain and arousal pathways to syndromal depression and anxiety. Mol Psychiatry (2009) 2.94

Stress, sensitive periods and maturational events in adolescent depression. Trends Neurosci (2008) 2.65

Altered emotional interference processing in affective and cognitive-control brain circuitry in major depression. Biol Psychiatry (2007) 2.61

The functional neuroanatomy of PTSD: a critical review. Prog Brain Res (2008) 2.56

The neural basis of mood-congruent processing biases in depression. Arch Gen Psychiatry (2002) 2.35

Persistent elevations of cerebrospinal fluid concentrations of corticotropin-releasing factor in adult nonhuman primates exposed to early-life stressors: implications for the pathophysiology of mood and anxiety disorders. Proc Natl Acad Sci U S A (1996) 2.30

A review on cognitive impairments in depressive and anxiety disorders with a focus on young adults. J Affect Disord (2007) 2.16

Neurobiological consequences of childhood trauma. J Clin Psychiatry (2004) 2.00

Attention, learning, and memory performances and intellectual resources in Vietnam veterans: PTSD and no disorder comparisons. Neuropsychology (2002) 1.88

Decreased working memory and processing speed mediate cognitive impairment in geriatric depression. Psychol Med (2000) 1.53

Association between depression severity and neurocognitive function in major depressive disorder: a review and synthesis. Neuropsychology (2010) 1.52

Neurobiology of posttraumatic stress disorder. CNS Spectr (2009) 1.48

Neurocognitive impairment in bipolar disorder patients: functional implications. Bipolar Disord (2009) 1.46

Learning and memory in combat veterans with posttraumatic stress disorder. Am J Psychiatry (1995) 1.44

Cognitive impairment in the remitted state of unipolar depressive disorder: a systematic review. J Affect Disord (2010) 1.29

Association of childhood trauma with cognitive function in healthy adults: a pilot study. BMC Neurol (2010) 1.13

Neuropsychological findings in childhood neglect and their relationships to pediatric PTSD. J Int Neuropsychol Soc (2009) 1.12

Role of adrenal steroid mineralocorticoid and glucocorticoid receptors in long-term potentiation in the CA1 field of hippocampal slices. Brain Res (1996) 1.07

Hippocampal volume in aging combat veterans with and without post-traumatic stress disorder: relation to risk and resilience factors. J Psychiatr Res (2006) 0.99

Neuropsychological impairment in major depression: its nature, origin and clinical significance. Aust N Z J Psychiatry (2007) 0.99

Neuropsychological processes in post-traumatic stress disorder. Psychiatr Clin North Am (2002) 0.96

Cognitive impairment and functioning in PTSD related to intimate partner violence. J Int Neuropsychol Soc (2009) 0.93

Introduction-posttraumatic stress disorder: a neurocognitive perspective. J Int Neuropsychol Soc (2009) 0.85

Hippocampal volume and declarative memory function in combat-related PTSD. J Int Neuropsychol Soc (2009) 0.83

Cognitive effects of intravenous hydrocortisone in subjects with PTSD and healthy control subjects. Ann N Y Acad Sci (2006) 0.82

Neurobehavioural and cognitive function is linked to childhood trauma in homeless adults. Br J Clin Psychol (2011) 0.79

Working memory performance and cognitive flexibility after dexamethasone or hydrocortisone administration in healthy volunteers. Psychopharmacology (Berl) (2011) 0.78

Articles by these authors

Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nat Rev Neurosci (2009) 11.02

Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. JAMA (2008) 6.60

Retracted An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer. J Clin Oncol (2007) 5.77

Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. Arch Gen Psychiatry (2007) 5.64

Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry (2005) 4.81

Determinants of real-world functional performance in schizophrenia subjects: correlations with cognition, functional capacity, and symptoms. Am J Psychiatry (2006) 4.77

Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions. Nat Neurosci (2012) 4.71

Influence of child abuse on adult depression: moderation by the corticotropin-releasing hormone receptor gene. Arch Gen Psychiatry (2008) 4.65

The role of dopamine in the pathophysiology of depression. Arch Gen Psychiatry (2007) 4.51

The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence. Am J Psychiatry (2005) 4.45

The link between childhood trauma and depression: insights from HPA axis studies in humans. Psychoneuroendocrinology (2008) 4.35

White matter changes in schizophrenia: evidence for myelin-related dysfunction. Arch Gen Psychiatry (2003) 4.25

Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat Genet (2004) 3.91

The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery. Schizophr Res (2004) 3.57

Predicting schizophrenia patients' real-world behavior with specific neuropsychological and functional capacity measures. Biol Psychiatry (2007) 3.42

Genetic control of human brain transcript expression in Alzheimer disease. Am J Hum Genet (2009) 3.35

Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress. Am J Psychiatry (2006) 3.33

Are mood disorders and obesity related? A review for the mental health professional. J Clin Psychiatry (2004) 3.26

Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology (2002) 3.24

Childhood trauma associated with smaller hippocampal volume in women with major depression. Am J Psychiatry (2002) 3.05

Chronic fatigue syndrome--a clinically empirical approach to its definition and study. BMC Med (2005) 2.97

The Schizophrenia Cognition Rating Scale: an interview-based assessment and its relationship to cognition, real-world functioning, and functional capacity. Am J Psychiatry (2006) 2.95

Early life programming and neurodevelopmental disorders. Biol Psychiatry (2010) 2.93

Baseline neurocognitive deficits in the CATIE schizophrenia trial. Neuropsychopharmacology (2006) 2.70

Self-assessment of functional status in schizophrenia. J Psychiatr Res (2006) 2.65

Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial. Am J Psychiatry (2005) 2.62

Prevalence of chronic fatigue syndrome in metropolitan, urban, and rural Georgia. Popul Health Metr (2007) 2.58

Assessment of community functioning in people with schizophrenia and other severe mental illnesses: a white paper based on an NIMH-sponsored workshop. Schizophr Bull (2006) 2.53

Depressive symptoms and viral clearance in patients receiving interferon-alpha and ribavirin for hepatitis C. Brain Behav Immun (2005) 2.52

Characterizing affective instability in borderline personality disorder. Am J Psychiatry (2002) 2.44

Prediction of real-world functional disability in chronic mental disorders: a comparison of schizophrenia and bipolar disorder. Am J Psychiatry (2010) 2.35

Long-term consequences of neonatal rearing on central corticotropin-releasing factor systems in adult male rat offspring. Neuropsychopharmacology (2005) 2.35

The effects of hypertension and body mass index on cognition in schizophrenia. Am J Psychiatry (2010) 2.33

Reduced glucocorticoid receptors: consequence or cause of depression? Trends Endocrinol Metab (2006) 2.26

Neuropsychological impairments in schizophrenia: Integration of performance-based and brain imaging findings. Psychol Bull (2007) 2.25

Administration and interpretation of the Trail Making Test. Nat Protoc (2006) 2.18

Neurobiological and psychiatric consequences of child abuse and neglect. Dev Psychobiol (2010) 2.17

Depression, desperation, and suicidal ideation in college students: results from the American Foundation for Suicide Prevention College Screening Project at Emory University. Depress Anxiety (2008) 2.16

Epidemiology of comorbid coronary artery disease and depression. Biol Psychiatry (2003) 2.13

Diffusion tensor imaging findings in first-episode and chronic schizophrenia patients. Am J Psychiatry (2008) 2.11

Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment. Biol Psychiatry (2003) 2.05

Importance of studying the contributions of early adverse experience to neurobiological findings in depression. Neuropsychopharmacology (2004) 2.03

Activation of central nervous system inflammatory pathways by interferon-alpha: relationship to monoamines and depression. Biol Psychiatry (2008) 1.96

Psychometric properties of the CDC Symptom Inventory for assessment of chronic fatigue syndrome. Popul Health Metr (2005) 1.94

Characteristics of the MATRICS Consensus Cognitive Battery in a 29-site antipsychotic schizophrenia clinical trial. Schizophr Res (2010) 1.91

CNS expression of glucocerebrosidase corrects alpha-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy. Proc Natl Acad Sci U S A (2011) 1.90

Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy. Am J Psychiatry (2003) 1.90

Evaluation of functionally meaningful measures for clinical trials of cognition enhancement in schizophrenia. Am J Psychiatry (2011) 1.86

Neuropsychological function and dysfunction in schizophrenia and psychotic affective disorders. Schizophr Bull (2008) 1.81

Anterior cingulate activation and error processing during interferon-alpha treatment. Biol Psychiatry (2005) 1.80

Long-term behavioural and molecular alterations associated with maternal separation in rats. Eur J Neurosci (2007) 1.79

The relationship of depression and diabetes: pathophysiological and treatment implications. Psychoneuroendocrinology (2011) 1.74

The role of early adverse experience and adulthood stress in the prediction of neuroendocrine stress reactivity in women: a multiple regression analysis. Depress Anxiety (2002) 1.72

The dexamethasone/corticotropin-releasing factor test in men with major depression: role of childhood trauma. Biol Psychiatry (2007) 1.71

Is schizophrenia a syndrome of accelerated aging? Schizophr Bull (2007) 1.70

Psychiatric comorbidity in persons with chronic fatigue syndrome identified from the Georgia population. Psychosom Med (2009) 1.69

Usefulness of the UCSD performance-based skills assessment (UPSA) for predicting residential independence in patients with chronic schizophrenia. J Psychiatr Res (2007) 1.67

Determinants of everyday outcomes in schizophrenia: the influences of cognitive impairment, functional capacity, and symptoms. Schizophr Res (2009) 1.66

Alterations in diurnal cortisol rhythm and acoustic startle response in nonhuman primates with adverse rearing. Biol Psychiatry (2005) 1.65

Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combination. Biol Psychiatry (2002) 1.65

Cognition in schizophrenia: impairments, determinants, and functional importance. Psychiatr Clin North Am (2005) 1.63

Basal ganglia hypermetabolism and symptoms of fatigue during interferon-alpha therapy. Neuropsychopharmacology (2007) 1.63

Polymorphisms of the glucocorticoid receptor gene and major depression. Biol Psychiatry (2006) 1.62

Hypercortisolemia and depression. Psychosom Med (2005) 1.60

Long-term adaptations in glucocorticoid receptor and mineralocorticoid receptor mRNA and negative feedback on the hypothalamo-pituitary-adrenal axis following neonatal maternal separation. Biol Psychiatry (2004) 1.59

A double blind placebo controlled trial of donepezil adjunctive treatment to risperidone for the cognitive impairment of schizophrenia. Biol Psychiatry (2002) 1.59

Effects of risperidone augmentation in patients with treatment-resistant depression: Results of open-label treatment followed by double-blind continuation. Neuropsychopharmacology (2006) 1.59

Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) Platelet Substudy. Circulation (2003) 1.59

Depression during pegylated interferon-alpha plus ribavirin therapy: prevalence and prediction. J Clin Psychiatry (2005) 1.58

Delivery of AAV-IGF-1 to the CNS extends survival in ALS mice through modification of aberrant glial cell activity. Mol Ther (2008) 1.57

Cognitive impairment in schizophrenia. Handb Exp Pharmacol (2012) 1.57

Elaboration on premorbid intellectual performance in schizophrenia: premorbid intellectual decline and risk for schizophrenia. Arch Gen Psychiatry (2005) 1.55

First do no harm: managing antihistamine impairment in patients with allergic rhinitis. J Allergy Clin Immunol (2003) 1.55

Psychometric comparison of computerized and standard administration of the neurocognitive assessment instruments selected by the CATIE and MATRICS consortia among patients with schizophrenia. Schizophr Res (2007) 1.55

Validating measures of real-world outcome: the results of the VALERO expert survey and RAND panel. Schizophr Bull (2009) 1.54

The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases. J Clin Psychiatry (2007) 1.54

Combined cognitive remediation and functional skills training for schizophrenia: effects on cognition, functional competence, and real-world behavior. Am J Psychiatry (2012) 1.53

Effects of interferon-alpha on rhesus monkeys: a nonhuman primate model of cytokine-induced depression. Biol Psychiatry (2007) 1.51

Microarray, qPCR, and KCNJ5 sequencing of aldosterone-producing adenomas reveal differences in genotype and phenotype between zona glomerulosa- and zona fasciculata-like tumors. J Clin Endocrinol Metab (2012) 1.50

Neurobiology of posttraumatic stress disorder. CNS Spectr (2009) 1.48

Correlations of functional capacity and neuropsychological performance in older patients with schizophrenia: evidence for specificity of relationships? Schizophr Res (2006) 1.47

Self-reported depressive symptom measures: sensitivity to detecting change in a randomized, controlled trial of chronically depressed, nonpsychotic outpatients. Neuropsychopharmacology (2005) 1.47

Orthostatic instability in a population-based study of chronic fatigue syndrome. Am J Med (2005) 1.47

Effects of lithium on cognitive performance: a meta-analysis. J Clin Psychiatry (2009) 1.46

Neurocognitive impairment in bipolar disorder patients: functional implications. Bipolar Disord (2009) 1.46

International Study to Predict Optimized Treatment for Depression (iSPOT-D), a randomized clinical trial: rationale and protocol. Trials (2011) 1.46

Augmenting CNS glucocerebrosidase activity as a therapeutic strategy for parkinsonism and other Gaucher-related synucleinopathies. Proc Natl Acad Sci U S A (2013) 1.45

Pharmacological treatment of cognition in schizophrenia: an idea whose method has come. Am J Psychiatry (2008) 1.44

Measuring the severity of depression and remission in primary care: validation of the HAMD-7 scale. CMAJ (2005) 1.42

Polymorphisms in CRHR1 and the serotonin transporter loci: gene x gene x environment interactions on depressive symptoms. Am J Med Genet B Neuropsychiatr Genet (2010) 1.42

Cerebrospinal fluid corticotropin-releasing factor and perceived early-life stress in depressed patients and healthy control subjects. Neuropsychopharmacology (2004) 1.41

Effect of Childhood Trauma on Adult Depression and Neuroendocrine Function: Sex-Specific Moderation by CRH Receptor 1 Gene. Front Behav Neurosci (2009) 1.41

Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT Study. J Clin Psychiatry (2007) 1.40

Atypical antipsychotic administration during late pregnancy: placental passage and obstetrical outcomes. Am J Psychiatry (2007) 1.38

Neurobiology of early life stress: clinical studies. Semin Clin Neuropsychiatry (2002) 1.38

Assessing everyday functioning in schizophrenia: not all informants seem equally informative. Schizophr Res (2011) 1.37

The role of SATB1 in breast cancer pathogenesis. J Natl Cancer Inst (2010) 1.36

Sensitivity of ICD-10 diagnosis of psychotic disorders in the Israeli National Hospitalization Registry compared with RDC diagnoses based on SADS-L. Compr Psychiatry (2005) 1.34

Milnacipran: a comparative analysis of human monoamine uptake and transporter binding affinity. Biol Psychiatry (2004) 1.32